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Heterochromatin plays an essential role in the preservation of 
epigenetic information, the transcriptional repression of repeti-
tive DNA elements and inactive genes, and the proper segregation 
of chromosomes during mitosis. Here we identify KDM2A, a 
JmjC-domain containing histone demethylase, as a heterochro-
matin-associated and HP1-interacting protein that promotes HP1 
localization to chromatin. We show that KDM2A is required 
to maintain the heterochromatic state, as determined using a 
candidate-based approach coupled to an in vivo epigenetic reporter 
system. Remarkably, a parallel and independent siRNA screen also 
detected a role for KDM2A in epigenetic silencing. Moreover, 
we demonstrate that KDM2A associates with centromeres and 
represses transcription of small non-coding RNAs that are encoded 
by the clusters of satellite repeats at the centromere. Dissecting 
the relationship between heterochromatin and centromeric RNA 
transcription is the basis of ongoing studies. We demonstrate that 
forced expression of these satellite RNA transcripts compromise the 
heterochromatic state and HP1 localization to chromatin. Finally, 
we show that KDM2A is required to sustain centromeric integ-
rity and genomic stability, particularly during mitosis. Since the 
disruption of epigenetic control mechanisms contributes to cellular 
transformation, these results, together with the low levels of 
KDM2A found in prostate carcinomas, suggest a role for KDM2A 
in cancer development.
Introduction
Heterochromatin is composed of highly repetitive satellite DNA 
and repressed genes, and this highly compacted and repressive envi-
ronment is mediated by the presence of heterochromatin-associated 
proteins and specific epigenetic markers.1,2 Centromeric hetero-
chromatin contains sequences that produce small non-coding RNA 
molecules required for maintaining the heterochromatin state and 
centromeric integrity.3-7
KDM2A is an evolutionarily conserved and ubiquitously expressed 
member of the KDM2 Lys histone demethylase family.8 Because it 
contains a JmjC-domain and an F-box motif, this protein is also 
known as JHDM1A and FBXL11, respectively.9,10 KDM2A was 
previously identified as a dimethyl Lys36 histone H3 (H3K36me2) 
histone demethylase.10 In this study, we characterize KDM2A as 
an integral heterochromatin-associated protein, and we show that 
KDM2A plays a crucial role in silencing centromeric satellite repeats 
and maintaining the heterochromatic state.
Results
To begin assessing the biological function of KDM2A, we inves-
tigated its cellular localization in interphase cells by using indirect 
immunofluorescence analysis. KDM2A localized to the nucleus 
of cells and showed a punctate staining pattern throughout the 
nucleoplasm and perinucleolar enrichment (Fig. 1A), as compared 
to the human paralogue KDM2B/JHDM1B, which was previously 
identified as a nucleolar-resident protein.11 Epe1, the fission yeast 
orthologue of KDM2, interacts with Swi6 [the yeast heterochro-
matin protein 1 (HP1) orthologue] and is distributed across all 
major heterochromatic domains, including pericentric heterochro-
matin.12 To determine if the punctate staining pattern of KDM2A 
reflected heterochromatin association, we performed colocalization 
experiments with KDM2A and the HP1 variants (HP1-α, HP1-β 
and HP1-γ). Indirect immunofluorescence demonstrated that 
KDM2A partially colocalized with heterochromatin foci associated 
with endogenous HP1 variants (Fig. 1B). Partial colocalization of 
KDM2A and HP1 proteins was calculated by the Pearson (rp) and 
Spearman correlation coefficients (rs)
13 (Fig. 1B and C). Notably, 
KDM2A was not observed to preferentially colocalize with any of the 
HP1 variants, which are known to differ slightly in their heterochro-
matic localization.1 Moreover, immunoprecipitation of exogenous 
HP1 variants showed association with endogenous KDM2A, but 
not KDM2B (Fig. 1D). Accordingly, an independent TAP-tagged 
immunopurification of KDM2A expressed in HEK-293T cells 
followed by mass spectrometry analysis of copurified endogenous 
proteins revealed the presence of peptides corresponding to HP1-α 
(NLD CPE LIS EFMK, SNF SNS ADDIK, LTW HAY PED AENK 
and WKD TDE ADL VLAK), HP1-β (GFS DED NTW EPE ENL 
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Figure 1. KDM2A localizes to heterochromatin and associates to HP1. (A) Indirect immunofluorescence analysis of HeLa cells transfected with constructs 
encoding FLAG-tagged KDM2A or FLAG-tagged KDM2B, as indicated. Cells were stained with an anti-FLAG antibody and DAPI. (B) Indirect immunofluo-
rescence analysis of U2OS cells transfected with a construct encoding FLAG-tagged KDM2A. Cells were stained with an anti-FLAG antibody, antibodies to 
heterochromatin protein 1 variants (HP1-α, HP1-β and HP1-γ), as indicated, and DAPI. Scatter-plots used to determine Pearson (rp) and Spearman correlation 
coefficients (rs) are shown. (C) Graph shows the average colocalization coefficients between KDM2A and HP1 proteins (n = 10, +/- SD), as determined 
by quantification of Pearson (rp) (open columns) and Spearman correlation coefficients (rs) (filled columns). The value given for 100% was set as 1. (D) 
Endogenous KDM2A, but not endogenous KDM2B, associates with HP1 variants. The indicated HA-tagged HP1 proteins were expressed in HEK-293T cells. 
Whole cell extracts (WCE) were subjected to immunoprecipitation with anti-HA resin followed by immunoblotting with antibodies to the indicated proteins. 
The asterisk indicates the IgG light chain.
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cells displayed a significant loss of HP1 heterochromatin-associated 
nuclear foci compared to control cells (Fig. 2C). Moreover, we 
observed a decrease in the amount of HP1-γ associated with chro-
matin in KDM2A siRNA-treated mitotic cells during anaphase 
(Fig. 2D and data not shown), at a time when HP1-γ is found to 
be  exclusively on DNA.17 These data suggest KDM2A knockdown 
results in the delocalization of HP1 from chromatin.
Because heterochromatin maintenance requires the presence 
of HP1 on chromatin, we sought to determine if the silencing of 
KDM2A compromises the overall heterochromatic state. To this end, 
we employed the use of epigenetically silent GFP (green fluorescent 
protein) reporter genes that have been integrated into the genome of 
HeLa cells.18,19 In these GFP(-) HeLa reporter cells, reactivation of 
GFP expression occurs following heterochromatin disruption, such 
as after HP1-γ knockdown or via inhibition of histone deacetylases 
by histone deacetylase inhibitors like trichostatin A.18,19 Using 
DCP DLI AEF LQS QK, KKV EEV LEE EEE EYV VEK, NSD 
EAD LVP AK and CPQ VVI SFY EER) and HP1-γ (VEE AEP EEF 
VVEK and LTW HSC PED EAQ). In addition, KDM2A was also 
independently identified by mass spectrometry analysis as an HP1-α 
interacting protein in a pool-down experiment using a GST-HP1-α 
fusion protein incubated with a HeLa nuclear extract (Kato H and 
Pagano M, unpublished results). Together, these data demonstrate 
that KDM2A is a heterochromatin-associated protein that interacts 
with HP1.
Heterochromatin-associated proteins have been shown to regulate 
HP1 localization and contribute to heterochromatin formation and 
maintenance in mammalian cells.1,2,14-16 Since KDM2A was found 
to localize to heterochromatin and associate with HP1, we examined 
the status of HP1 on chromatin following KDM2A knockdown in 
mouse NIH-3T3 and human HeLa cells (Fig. 2A and B). Indirect 
immunofluorescence of HP1-γ in KDM2A knockdown mouse 
Figure 2. KDM2A maintains the heterochromatic state. (A) Representative example showing knockdown efficiency for KDM2A siRNA oligos by Western blot. 
Immunoblot of cell extracts from NIH-3T3 cells transfected with control oligos or KDM2A siRNA oligos. Efficacy of siRNA was assessed by immunoblotting 
to detect KDM2A, and α-Tubulin levels were used as loading controls. (B) Immunoblot of cell extracts from HCT-116 cells transfected with control oligos or 
KDM2A siRNA oligos. Efficacy of siRNA was assessed by immunoblotting as in (A). (C) Representative indirect immunofluorescence of HP1-γ in NIH-3T3 
cells transfected with control oligos or KDM2A siRNA oligos. Cells were pre-extracted with TritonX-100 detergent prior to fixation and permeabilization with 
100% methanol to visualize loss of HP1-γ. (D) Representative indirect immunofluorescence of HP1-γ in mitotic HeLa cells transfected with control oligos or 
KDM2A siRNA oligos. (E) Reactivation of a GFP reporter gene in GFP(-) HeLa cells transfected with control or KDM2A-siRNA oligos as measured by FACS. 
(F) Reactivation of a GFP reporter gene in GFP(-) HeLa cells transfected with control, HDAC1, KDM2A or KDM2B siRNA oligos as measured by FACS.
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is associated with positive regulation of Pol II-mediated transcrip-
tion23 and is negatively regulated by KDM2A.8 In agreement with an 
increase in α-satellite transcription, ChIP analysis at the pericentric 
region of human chromosome 4 in KDM2A siRNA-treated cells 
displayed a significant increase in the levels of H3K36me2, but not 
H3K9me3, compared to control (Figs. 3D and S2), while the levels 
of H3K36me2 and H3K9me3 at the GAPDH promoter were unaf-
fected (Figs. 3D and S2).
Since KDM2A repressed α-satellite transcription in human cells, 
we also investigated whether KDM2A contributed to the transcrip-
tional regulation of repetitive DNA sequences within the centromeric 
heterochromatin of murine cells by using previously characterized 
primers for analyzing minor and major satellite repeats.3,16 Major 
satellite repeats surround the minor satellites, and these two sets 
of repeats are separated by short stretches of CG-rich sequences24 
that may provide an ideal platform for the DNA-binding capa-
bilities of KDM2A.22 Semi-quantitative RT-PCR on total RNA in 
KDM2A-depleted NIH-3T3 cells displayed a substantial increase in 
the transcription of the major, but not the minor, satellite repeats 
compared to control cells (Fig. 3E). Taken together, these data 
demonstrate that KDM2A is a transcriptional repressor of pericen-
tric α-satellite and major satellite repeats in human and mouse cells, 
respectively.
KDM2A specifically demethylates H3K36me2,10 and since we 
observed an increase in H3K36me2 at pericentric chromosome 4 
following KDM2A knockdown (Fig. 3D), we determined whether 
the JmjC-domain of KDM2A is required for satellite silencing in 
mammalian cells. Constructs encoding human KDM2A and a JmjC-
domain mutant [KDM2A(ΔJmjC)] were introduced into NIH-3T3 
cells that were previously treated with siRNA oligos against murine 
KDM2A. KDM2A siRNA-treated NIH-3T3 cells exogenously 
expressing human (and therefore siRNA insensitive) KDM2A 
displayed a significant decrease in major satellite RNA transcription 
compared to KDM2A siRNA-treated NIH-3T3 cells transfected 
with an empty vector (Fig. 3F). In contrast, KDM2A(ΔJmjC) was 
unable to rescue this effect due to KDM2A downregulation (Fig. 
3F), suggesting a role for histone demethylation in the inhibition of 
transcription by KDM2A.
Dissecting the relationship between heterochromatin and centro-
meric RNA transcription is the basis of ongoing studies.25-27 Given 
the reactivation of GFP expression in GFP(-) HeLa reporter cells 
detected in KDM2A siRNA treated cells (Fig. 2E and F) and the 
increase in α-satellite transcription observed following KDM2A 
knockdown (Fig. 3C), we sought to determine if forced accumula-
tion of satellite RNA transcripts compromise the heterochromatic 
state. To that end, we transfected GFP(-) HeLa reporter cells with 
an expression vector driving transcription of one α-satellite repeat 
(171-bp monomer) from a human chromosome (chromosome 4) and 
monitored reactivation of GFP expression (Fig. 3G). Remarkably, we 
found that cells exogenously expressing these centromeric RNAs 
exhibited reactivation of GFP compared to cells transfected with an 
empty vector (Fig. 3G). Similarly, indirect immunofluorescence of 
HP1-γ in NIH-3T3 cells exogenously expressing major satellite RNA 
transcripts displayed a significant loss of HP1 heterochromatin-
associated nuclear foci compared to cells transfected with an empty 
vector (Fig. 3H). These data suggest that the accumulation of satellite 
transcripts observed in KDM2A depleted cells (Fig. 3C and E) may 
these reporter cells, we found that knockdown of KDM2A, but 
not KDM2B, resulted in the robust reactivation of GFP compared 
to cells transfected with a control siRNA (Fig. 2E). These results 
suggest KDM2A is involved in heterochromatin maintenance similar 
to Epe1.7,12,20,21 Strikingly, an independent siRNA library screen 
utilizing these GFP(-) HeLa reporter cells (performed by Poleshko 
A and Katz R, manuscript in preparation) identified KDM2A, but 
not KDM2B, as a gene involved in the maintenance of epigenetic 
silencing (Fig. 3F). Thus, these observations are consistent with a role 
of KDM2A as a regulator of the heterochromatic state.
All HP1 variants associate with centromeric heterochromatin.1 
Thus, we investigated whether KDM2A was associated with centro-
meric heterochromatin by examining the localization of KDM2A 
in comparison with the centromeric protein CENP-A (centromere 
protein A). In interphase cells, we observed partial KDM2A colo-
calization with CENP-A, including within the heterochromatin 
that surrounds the nucleolus (Fig. S1). In areas where colocalization 
between KDM2A and CENP-A was not observed, we detected 
KDM2A foci immediately adjacent to centromeric regions (Fig. 
S1). Partial colocalization of KDM2A and CENPA was calculated 
by the Pearson (rp) and Spearman correlation coefficients (rs)
13 
(Fig. S1). Moreover, we investigated whether KDM2A was associ-
ated with centromeric heterochromatin by performing chromatin 
immunoprecipitation (ChIP) assays followed by quantitative real-
time polymerase chain reaction (PCR) using primers spanning 
the pericentric region of a human chromosome (chromosome 4). 
KDM2A was found to bind to this region of chromosome 4 (Fig. 
3A), and the specificity of this binding was confirmed by the fact 
that a DNA-binding mutant [KDM2A(CXXC)] and KDM2B failed 
to bind to this locus. The lack of significant enrichment of KDM2A 
on a housekeeping gene promoter (GAPDH) (data not shown), 
further validated specificity for pericentric loci. Treatment of these 
DNA complexes with the methylation-sensitive HpaII (5'-CCGG-
3') enzyme abolished the binding of KDM2A to the pericentric 
region of human chromosome 4 (Fig. 3A), suggesting recognition by 
KDM2A to unmethylated CpG sequences at this locus. Thus, these 
data show that KDM2A is enriched at pericentric heterochromatin 
and binds to CpG islands, as predicted based on the presence of the 
CXXC DNA-binding motif.22
In fission yeast and in higher eukaryotic cells, small RNA molecules 
transcribed by RNA polymerase II (Pol II) from within centromeric 
and pericentromeric regions appear to be necessary to initiate and 
sustain repressive chromatin modifications.3-7 In human cells, the 
primary repetitive DNA at centromeres is α-satellite DNA, which 
consists of a 171-bp monomer that is tandemly arranged into higher-
order arrays that extend for 100-kb to several megabases. Given that 
KDM2B was characterized as a transcriptional repressor of ribosomal 
RNA genes,11 which are also encoded by tandem DNA repeats 
within the nucleolus, we investigated whether KDM2A contrib-
uted to the transcriptional regulation of repetitive α-satellite DNA 
sequences within centromeric heterochromatin in human HCT-116 
cells. Using previously reported primers for analyzing transcription 
of these repeats, we conducted semi-quantitative RT-PCR on total 
RNA from KDM2A-depleted HCT-116 cells (Fig. 3B). We observed 
an increase in the transcription of the α-satellite transcripts of chro-
mosomes 2, 4 and 13/21 in KDM2A-depeleted cells compared to 
control cells (Fig. 3C). H3K36me2 is a histone modification that 
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Figure 3. For figure legend, see page 6.
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prostate cancer tissues compared to normal tissues.32 In addition, 
an elevated frequency of chromosomal rearrangements is observed 
in the centromeric regions of prostate cancer patients,33 which is 
consistent with the loss of centromeric integrity associated with 
decreased levels of HP1 and heterochromatin stability. To investigate 
a potential involvement of KDM2A in prostate cancer, we searched 
the Oncomine on-line databases for differential KDM2A expression 
in normal versus tumorigenic prostate tissues. Interestingly, in 4 out 
of 4 studies, the expression of KDM2A, but not KDM2B, was found 
significantly decreased in prostate carcinomas compared to normal 
prostate tissue (Figs. 4C; S3 and S4). Furthermore, a fifth study 
showed that the decrease in KDM2A expression was correlated with 
prostate tumor grade (Fig. S2). Taken together, these results suggest 
that the decrease in KDM2A levels may contribute to the high 
incidences of centromeric rearrangements and mitotic aberrations 
observed in prostate carcinomas.
Discussion
Abnormal chromosome segregation is a common characteristic of 
human tumors, and many of the molecular origins of chromosome 
missegregation derive from defective centromere and kinetochore 
assembly and function.31 While mutations and/or the altered expres-
sion of genes that impinge on kinetochore function may impact 
chromosome segregation, recent studies have focused on character-
izing the function of non-coding RNAs derived from centromeric 
repeats in the formation and maintenance of heterochromatin in 
supporting proper centromere function.
Here we show that KDM2A localizes to heterochromatin and 
binds HP1 proteins. As HP1 interactors provide various possi-
bilities for HP1-binding to sites that may not have intrinsically 
strong affinity for HP1, the association of KDM2A and HP1 
may contribute to the stability of HP1 on chromatin that displays 
be responsible for the disruption of heterochromatin and HP1 local-
ization following the downregulation of KDM2A (Fig. 2).
RNA transcripts generated from within pericentric hetero-
chromatin are thought to assist in the maintenance of centromere 
structure,26 and interactions with single-stranded RNA molecules 
are required for integrity of the kinetochore structure in mitosis.28 
Importantly, while RNA molecules are required for centromeric 
integrity, the accumulation of satellite transcripts may lead to defects 
in chromosome segregation and mislocalization of centromere-
associated proteins essential for centromere function.6 Based on 
these reports, we determined whether silencing of KDM2A impacted 
centromere integrity and chromosome segregation in mitosis. We 
analyzed HCT-116 cells, which have a relatively stable karyotype,29 
transfected with control or KDM2A siRNA oligos and conducted 
indirect immunofluorescence analysis of CENP-A and α-tubulin 
to determine the state of centromeres and the mitotic spindle, 
respectively. While the mitotic spindle appeared unaffected, knock-
down of KDM2A resulted in an increase in the misalignment of 
centromeres along the metaphase plate (36%, 45/125), as visualized 
with CENP-A, compared to control (12%, 15/125) (Fig. 4A). This 
phenotype was accompanied by segregation defects that were revealed 
by the detection of chromosome breaks (Fig. 4A) and a dramatic 
increase in the amount of chromosome bridges in KDM2A-siRNA 
treated cells (51%, 89/174) compared to control cells (16%, 38/228) 
(Fig. 4B). Together, these data suggest that KDM2A-mediated regu-
lation of satellite RNAs and maintenance of heterochromatin may 
result in the loss of mitotic fidelity.
The loss of centromeric integrity, minor changes in the expres-
sion of non-coding RNAs and the deregulation of heterochromatin 
contribute to cellular transformation and genomic instability.6,30,31 
As such, a recent study has demonstrated that HP1 variants 
display decreased expression levels in prostate cancer cell lines and 
Figure 3. KDM2A represses transcription of pericentric satellite repeats in a JmjC-dependent manner. (A) KDM2A binds to the pericentric region of a human 
chromosome. Enrichment at the pericentric region of human chromosome 4 was obtained with anti-FLAG antibody as determined by ChIP analysis using 
chromatin prepared from HEK-293T cells transfected with FLAG-EV (empty vector), FLAG-KDM2A, FLAG-KDM2A(CXXC) and FLAG-KDM2B (open columns). 
Enrichment at the pericentric region of human chromosome 4 was additionally obtained after DNA complexes were treated with the methylation-sensitive 
HpaII (5'-CCGG-3') enzyme that only cleaves unmethylated CpG sequences (closed columns). DNA-binding was quantified by real-time PCR. The value 
given for the amount of PCR product in EV-transfected cells was set at 1 (n = 3, +/- SD). (B) Representative example showing knockdown efficiency for 
KDM2A siRNA oligos by Western blot. Immunoblot of cell extracts from HCT-116 cells transfected with control oligos or KDM2A siRNA oligos. Efficacy of 
siRNA was assessed by immunoblotting to detect KDM2A, and α-Tubulin levels were used as loading controls. (C) RT-PCR analysis with oligo-dT-primed, 
reverse-transcribed (RT) cDNA derived from total RNA that was prepared from HeLa cells transfected with control or KDM2A siRNA oligos. PCR amplification 
using 25 cycles was conducted using locus-specific primers for the indicated chromosome satellites and ARPP P0 (as control). Panel on the right shows the 
quantification of α-satellite RNA expression in (C) averaged with one additional, independent experiment. Levels of ARPP P0 were used for normalization. 
The value given for the amount of α-satellite RNAs in control siRNA cells was set as 1 (n = 2, +/- SD). (D) Increase of H3K36me2 at the pericentric region 
of human chromosome 4 after downregulation of KDM2A. Analysis of H3K36me2 at the pericentric region of human chromosome 4 (open columns) and 
the GAPDH promoter (closed columns). ChIP was performed as in (A) with samples from cells treated with control (open columns) or KDM2A (filled columns) 
siRNA. The value given for the amount of PCR product present in IgG control samples was set at 1 (n = 3, +/- SD). (E) RT-PCR was conducted as in (C) 
using NIH-3T3 cells transfected with control or KDM2A siRNA oligos specific for mouse cells. Locus-specific primers for major and minor satellite repeats and 
levels of GAPDH (as control) were used. (F) RT-PCR analysis of major satellite repeats and GAPDH in KDM2A siRNA-treated NIH-3T3 cells, as performed 
as in (E), following transfection with vectors encoding FLAG-tagged KDM2A or FLAG-tagged KDM2A(JmjC). KDM2A expression levels were analyzed by 
immunoblotting using anti-FLAG antibody. Panel on the right shows the quantification of Major satellite RNA expression in (E) averaged with one additional, 
independent experiment. Levels of GAPDH were used for normalization. The value given for the amount of Major satellite RNAs in control cells (EV) was 
set as 1 (n = 2, +/- SD). (G) Forced expression of an α-satellite repeat results in disruption of heterochromatin. RT-PCR was conducted as in (C) using HeLa 
cells transfected with an empty expression vector (EV) or an expression vector driving transcription of one α-satellite repeat (171-bp) from a human chromo-
some (chromosome 4). Locus-specific primers for RNAs encoded by a4 and GAPDH (as control) were used. Panel on the right shows quantification of the 
expression of a GFP reporter gene in GFP(-) HeLa cells transfected with an empty expression vector (EV) or an expression vector driving transcription of one 
α-satellite repeat (171-bp) from human chromosome 4 (n = 300, +/- SD). (H) Forced expression of major satellite repeats results in HP1 delocalization from 
chromatin. Representative indirect immunofluorescence of HP1-γ in NIH-3T3 cells transfected with an empty expression vector (EV) or an expression vector 
driving transcription of one major satellite repeat. Cells were pre-extracted with TritonX-100 detergent prior to fixation and permeabilization with 100% 
methanol to visualize loss of HP1-γ.
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of epigenetic control mechanisms contribute to cellular transforma-
tion, our study provides critical insight into the role of aberrant 
transcription of centromeric satellite repeats in heterochromatin 
maintenance for fidelity in mitosis.
Materials and Methods
Cell culture. HeLa, HeLa(-GFP), HEK-293T, HCT-116 and 
NIH-3T3 cells were cultured as described previously.11,18,29,35
Transcription analysis by RT-PCR. Total RNA was extracted 
from NIH-3T3 the use of the RNeasy kit (Qiagen), and reverse 
transcriptions were performed as described previously.11 RT-PCR 
procedures and the primers used for α-satellites and major and minor 
satellites were as described previously.3,28
RNA interference. Cells were transfected by using HiPerFect 
transfection reagent (Qiagen), in accordance with the manufac-
turer’s protocol, with pool of four siRNA oligonucleotides (5'-CAA 
CAG CGA UCC CAA GUUA-3', 5'-GGA CAC GGG UUC CAA 
AUAA-3', 5'-CAA CAU CCC UAU GCA GUUA-3' and 5'-GCA 
AGC AGA UCA CUC GAAA-3') targeting human KDM2A 
(Dharmacon) and with pool of four siRNA oligonucleotides (5'-CAA 
GAA UUC UGA UGG ACUU-3', 5'-GAG AUU GCG UGG UAC 
specific epigenetic marks on DNA or nucleosomes. Moreover, we 
show KDM2A is essential for maintaining the heterochromatic 
state. We also show that KDM2A provides a fundamental function 
for silencing the transcription of satellite RNAs that are embedded 
within centromeric repeats in a JmjC-domain dependent manner. 
Implicating the regulation of satellite RNA expression in hetero-
chromatin maintenance, we demonstrate that forced accumulation 
of RNA transcripts encoded by centromeric satellite repeats compro-
mises heterochromatin stability and HP1 localization.
Intriguingly, the molecular function of KDM2A uniquely paral-
lels that of the human paralogue KDM2B, which localizes to a 
particular cellular compartment (the nucleolus) and binds DNA 
repeats (ribosomal) to modulate expression of ribosomal RNAs.11 
Equally noteworthy is that the fission yeast orthologue of KDM2A 
(Epe1) interacts with the S. pombe HP1 orthologue (Swi6) and 
plays a central role in maintaining heterochromatin and protecting 
centromere function and chromosome segregation fidelity.7,12,20,21 
Since a natural mutation in the catalytic region of the JmjC-domain 
of Epe1 is considered to render the protein a catalytically inactive 
histone demethylase,34 the requirement for the JmjC-domain in 
Epe1 function is currently not entirely understood. As the disruption 
Figure 4. Silencing of KDM2A compromises mitotic fidelity and low levels of KDM2A are found in prostate cancer. (A) Indirect immunofluorescence analysis 
of mitotic HCT-116 cells transfected with control or KDM2A siRNA oligos. Cells were stained with antibodies to CENP-A (centromere protein A) and α-Tubulin, 
as indicated, and DAPI. Panel on the right shows the percentage of mitotic cells with misaligned centromeres in HCT-116 cells transfected with control or 
KDM2A siRNA oligos. (B) Representative chromosome bridges observed in HCT-116 cells transfected with control or KDM2A siRNA oligos. Chromosome 
bridges were visualized by phosphorylated histone H3 immunostaining. Panel on the right shows the percentage of mitotic cells with chromosome bridges 
in HCT-116 cells transfected with control or KDM2A siRNA oligos. (C) KDM2A expression data from Dhanasekaran et al., 2001. Normal indicates normal 
prostate from adult tissues, and cancer indicates prostate carcinoma.
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as described previously.13 Images were prepared in Adobe Photoshop 
CS3 and ImageJ.
FACS analysis. FACS analysis to detect GFP was conducted as 
previously described.18,19
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